Literature DB >> 12000739

Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens.

Mylène Potier1, Michael Karl, Feng Zheng, Sharon J Elliot, Gary E Striker, Liliane J Striker.   

Abstract

The development and progression of glomerulosclerosis (GS) is determined by the genetic background. The incidence of end-stage renal disease is increased in postmenopausal women, suggesting that estrogen deficiency may play a role in the accumulation of extracellular matrix by mesangial cells (MCs), which are primarily responsible for the synthesis and degradation of this matrix. Using mouse models that are prone or resistant to the development of GS, we compared the expression of estrogen receptor (ER)-alpha and ER-beta subtypes in GS-prone and GS-resistant glomeruli and isolated MCs, and examined the effects of estrogens on ER, collagen, and matrix metalloproteinase (MMP) expression in MCs. Glomeruli and MCs from GS-prone mice had decreased expression of ER-alpha and ER-beta subtypes and ER transcriptional activity was also decreased in their MCs. Importantly, although 17 beta-estradiol treatment resulted in decreased collagen accumulation and increased MMP-9 expression and activity in MCs from GS-resistant mice, there was, paradoxically, no effect on collagen accumulation and decreased MMP-9 expression and activity in MCs from GS-prone mice. Thus, GS susceptibility is associated with diminished ER expression in MCs. The renal protective effects of estrogens, including decreased collagen accumulation and increased MMP-9 expression, seem to be blunted in GS-prone MCs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000739      PMCID: PMC1850880          DOI: 10.1016/S0002-9440(10)61134-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.

Authors:  D L Crowe; T N Brown
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.

Authors:  D L Crowe; K J Tsang; B Shemirani
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

3.  Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9.

Authors:  Mylene Potier; Sharon J Elliot; Ivan Tack; Oliver Lenz; Gary E Striker; Liliane J Striker; Michael Karl
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

4.  Detection of estrogen receptor alpha and beta messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons.

Authors:  M J Skynner; J A Sim; A E Herbison
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

5.  Estrogen directly respresses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons.

Authors:  D Roy; N L Angelini; D D Belsham
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

6.  Matrix accumulation in mesangial cells exposed to cyclosporine A requires a permissive genetic background.

Authors:  A Fornoni; O Lenz; I Tack; M Potier; S J Elliot; L J Striker; G E Striker
Journal:  Transplantation       Date:  2000-08-27       Impact factor: 4.939

7.  Suppression of estrogen-dependent MMP-9 expression by Edpm5, a genetic locus for pituitary tumor growth in rat.

Authors:  R V Sclafani; D L Wendell
Journal:  Mol Cell Endocrinol       Date:  2001-05-15       Impact factor: 4.102

Review 8.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.

Authors:  S A Bustin
Journal:  J Mol Endocrinol       Date:  2000-10       Impact factor: 5.098

9.  Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade.

Authors:  J Neugarten; I Medve; J Lei; S R Silbiger
Journal:  Am J Physiol       Date:  1999-12

Review 10.  Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

Authors:  B S Katzenellenbogen; I Choi; R Delage-Mourroux; T R Ediger; P G Martini; M Montano; J Sun; K Weis; J A Katzenellenbogen
Journal:  J Steroid Biochem Mol Biol       Date:  2000-11-30       Impact factor: 4.292

View more
  28 in total

Review 1.  Nuclear receptors in renal disease.

Authors:  Moshe Levi
Journal:  Biochim Biophys Acta       Date:  2011-04-14

Review 2.  Nuclear hormone receptors in diabetic nephropathy.

Authors:  Xiaoxin X Wang; Tao Jiang; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

Review 3.  Sexual dimorphism in the aging kidney: differences in the nitric oxide system.

Authors:  Chris Baylis
Journal:  Nat Rev Nephrol       Date:  2009-06-02       Impact factor: 28.314

4.  Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo.

Authors:  Michael Karl; Mariana Berho; Judith Pignac-Kobinger; Gary E Striker; Sharon J Elliot
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 5.  Sexual dimorphism: the aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity.

Authors:  Chris Baylis
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-07       Impact factor: 6.053

6.  Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.

Authors:  Jun Tashiro; Sharon J Elliot; David J Gerth; Xiaomei Xia; Simone Pereira-Simon; Rhea Choi; Paola Catanuto; Shahriar Shahzeidi; Rebecca L Toonkel; Rahil H Shah; Fadi El Salem; Marilyn K Glassberg
Journal:  Transl Res       Date:  2015-09-18       Impact factor: 7.012

7.  Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency.

Authors:  Chris Baylis
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

8.  Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.

Authors:  Helen Vlassara; Jaime Uribarri; Luigi Ferrucci; Weijing Cai; Massimo Torreggiani; James B Post; Feng Zheng; Gary E Striker
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

9.  In vivo 17β-estradiol treatment contributes to podocyte actin stabilization in female db/db mice.

Authors:  Paola Catanuto; Alessia Fornoni; Simone Pereira-Simon; Fayi Wu; Kerry L Burnstein; Xiaomei Xia; Francesco Conti; Andrea Lenzi; Sharon Elliot
Journal:  Endocrinology       Date:  2012-10-15       Impact factor: 4.736

10.  Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome.

Authors:  Gil-Jin Shim; Margaret Warner; Hyun-Jin Kim; Sandra Andersson; Lining Liu; Jenny Ekman; Otabek Imamov; Margaret E Jones; Evan R Simpson; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.